Clovis Oncology (NASDAQ:CLVS)

CAPS Rating: 1 out of 5

Recs

0
Player Avatar spiritof78 (97.31) Submitted: 5/4/2013 8:43:36 AM : Underperform Start Price: $37.92 CLVS Score: -87.82

Story driven, bio-pharm is big risk big reward and while they have two oncology drug lines...not really my cup of tea

Featured Broker Partners


Advertisement